We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Veru
VERU
$44.5M
| $83.4K | ﹤0.01% |
1,580
+113
| +8% | +$9.3K |
|
|
INN
2152
Summit Hotel Properties
INN
$670M
| $81K | ﹤0.01% |
11,223
-16
| -0.1% | -$125 |
|
|
PNT
2153
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $77.4K | ﹤0.01% |
+10,615
| New | +$78.8K |
|
2154
AvePoint
AVPT
$2.75B
| $76.3K | ﹤0.01% |
18,556
-3,173
| -15% | -$13.6K |
|
|
CANO
2155
DELISTED
Cano Health, Inc.
CANO
| $76.1K | ﹤0.01% |
+555
| New | +$188K |
|
2156
Custom Truck One Source
CTOS
$2.42B
| $75.1K | ﹤0.01% |
11,885
+382
| +3% | +$2.48K |
|
|
TGAN
2157
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $71.8K | ﹤0.01% |
13,191
-5,185
| -28% | -$30.5K |
|
2158
Gevo
GEVO
$388M
| $71.7K | ﹤0.01% |
37,721
+8,562
| +29% | +$18.1K |
|
2159
American Well
AMWL
$231M
| $70.6K | ﹤0.01% |
+1,247
| New | +$89.9K |
|
|
PFSW
2160
DELISTED
PFSweb, Inc.
PFSW
| $69K | ﹤0.01% |
11,224
-3,358
| -23% | -$31.4K |
|
2161
Hims & Hers Health
HIMS
$7.35B
| $67.1K | ﹤0.01% |
10,468
+62
| +0.6% | +$353 |
|
2162
Xeris Biopharma Holdings
XERS
$1.46B
| $66.8K | ﹤0.01% |
50,254
+29,712
| +145% | +$41.9K |
|
|
VMEO
2163
DELISTED
Vimeo
VMEO
| $64.8K | ﹤0.01% |
+19,449
| New | +$75.2K |
|
|
TTCF
2164
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $61.6K | ﹤0.01% |
+50,099
| New | +$149K |
|
2165
EVgo
EVGO
$500M
| $61.2K | ﹤0.01% |
+13,696
| New | +$88.5K |
|
2166
Marathon Digital Holdings
MARA
$3.69B
| $61K | ﹤0.01% |
+17,845
| New | +$150K |
|
2167
BGC Group
BGC
$4.86B
| $59.9K | ﹤0.01% |
+15,880
| New | +$62.7K |
|
2168
Arbutus Biopharma
ABUS
$907M
| $53K | ﹤0.01% |
22,753
-69
| -0.3% | -$165 |
|
2169
Aurinia Pharmaceuticals
AUPH
$2.06B
| $51.6K | ﹤0.01% |
+11,956
| New | +$69.4K |
|
2170
Joby Aviation
JOBY
$8.71B
| $50.1K | ﹤0.01% |
+14,941
| New | +$60.5K |
|
|
FXLV
2171
DELISTED
F45 Training Holdings Inc.
FXLV
| $41.4K | ﹤0.01% |
14,535
+137
| +1% | +$416 |
|
|
RIDE
2172
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $39.1K | ﹤0.01% |
+2,288
| New | +$53.1K |
|
2173
ESS Tech
GWH
$17.1M
| $35.2K | ﹤0.01% |
+965
| New | +$49.5K |
|
2174
Workhorse Group
WKHS
$34.5M
| $35K | ﹤0.01% |
+8
| New | +$55.1K |
|
|
EQRX
2175
DELISTED
EQRx, Inc. Common Stock
EQRX
| $31.7K | ﹤0.01% |
12,896
+633
| +5% | +$2.49K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.